These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


130 related items for PubMed ID: 8734949

  • 1. Complete immunization against Trypanosoma cruzi verified in individual mice by complement-mediated lysis.
    Gómez LE, Nasser JR, Basombrío MA.
    Mem Inst Oswaldo Cruz; 1996; 91(1):55-61. PubMed ID: 8734949
    [Abstract] [Full Text] [Related]

  • 2. Relationship between long-term resistance to Trypanosoma cruzi and latent infection, examined by antibody production and polymerase chain reaction in mice.
    Basombrío MA, Segura MA, Nasser JR.
    J Parasitol; 2002 Dec; 88(6):1107-12. PubMed ID: 12537102
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of IFN-γ coding plasmid supplementation in the immune response and protection elicited by Trypanosoma cruzi attenuated parasites.
    Pérez Brandán C, Mesías AC, Parodi C, Cimino RO, Pérez Brandán C, Diosque P, Basombrío MÁ.
    BMC Infect Dis; 2017 Nov 25; 17(1):732. PubMed ID: 29178839
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Immunologic protection against Chagas disease. Independent effects upon infection, dissemination and lesions of Trypanosoma cruzi].
    Basombrio MA, Mora MC, Segura MA.
    Medicina (B Aires); 1989 Nov 25; 49(3):191-6. PubMed ID: 2518641
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Trypanosoma cruzi: protection in mice immunized with 8-methoxypsoralen-inactivated trypomastigotes.
    Andrews NW, Alves MJ, Schumacher RI, Colli W.
    Exp Parasitol; 1985 Dec 25; 60(3):255-62. PubMed ID: 3935472
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease.
    Bontempi IA, Vicco MH, Cabrera G, Villar SR, González FB, Roggero EA, Ameloot P, Callewaert N, Pérez AR, Marcipar IS.
    Vaccine; 2015 Mar 03; 33(10):1274-83. PubMed ID: 25625671
    [Abstract] [Full Text] [Related]

  • 14. Immunization against a challenge with insect vector, metacyclic forms of Trypanosoma cruzi simulating a natural infection.
    Villalta F, Kierszenbaum F.
    Am J Trop Med Hyg; 1983 Mar 03; 32(2):273-6. PubMed ID: 6404187
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Suppression of cell-mediated immunity in experimental Chagas' disease.
    Reed SG, Larson CL, Speer CA.
    Z Parasitenkd; 1977 Jun 03; 52(1):11-7. PubMed ID: 407736
    [Abstract] [Full Text] [Related]

  • 17. Protective immunity and pathology induced by inoculation of mice with different subcellular fractions of Trypanosoma cruzi.
    Ruiz AM, Esteva M, Cabeza Meckert P, Laguens RP, Segura EL.
    Acta Trop; 1985 Dec 03; 42(4):299-309. PubMed ID: 2868632
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunization with Trypanosoma cruzi epimastigote antigens incorporated into iscoms protects against lethal challenge in mice.
    Araujo FG, Morein B.
    Infect Immun; 1991 Sep 03; 59(9):2909-14. PubMed ID: 1908826
    [Abstract] [Full Text] [Related]

  • 20. Use of Tc-rCRP as a target for lytic antibody titration after experimental Trypanosoma cruzi infection.
    Marques T, Silva GC, Henrique Paiva PM, Nascentes GAN, Ramirez LE, Norris K, Meira WSF.
    Exp Parasitol; 2018 Jan 03; 184():103-108. PubMed ID: 29246832
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.